Product category:
Mass spectrometers
News Release from: Shimadzu Biotech | Subject: Axima-Tof2
Edited by the Laboratorytalk Editorial
Team on 05 June 2006
High-energy Maldi CID MS/MS enhances
bio-research
The Axima-Tof2 is said to be ideal for use in open-access lab environments, delivering maximum results while requiring the minimum in user input
Shimadzu Biotech has introduced the Axima-Tof2, its new Maldi based high-performance Tof-Tof mass spectrometer Representing the next generation in high-energy collision induced dissociation (CID) MS/MS instrumentation, the Axima-Tof2 brings enhanced flexibility to life science laboratories, significantly extending the type of analyses they can provide
This article was originally published on Laboratorytalk on 30 Jun 2003 at 8.00am (UK)
Related stories
New solution for micro-scale proteomics
Chemical inkjet printer offers a new approach to peptide mass fingerprinting and protein macroarray analysis with widespread applications in biomedical and diagnostic discovery
Matrix-less Maldi for analysis of small molecules
Targets are used to identify low molecular weight compounds in matrix assisted laser desorption ionisation (Maldi) mass spectrometers
The device was introduced today at the 54th American Society of Mass Spectrometry Conference in Seattle.
With Shimadzu Biotech's intuitive software bundled as standard, the Axima-Tof2 is said to be ideal for use in open-access lab environments, delivering maximum results while requiring the minimum in user input.
As a result, the system is equally robust and reliable whether employed by novices, or expert users, while the inclusion of industry standard XML data exporting allows it to integrate easily and seamlessly into any workflow.
Further reading
R and D award for chemical inkjet printer
Novel technology offers researchers a revolutionary new approach to automatic protein processing, identification and characterisation
Mtec 2004 preview: ABB
ABB will be presenting the latest technology from its comprehensive range of instrumentation products and systems at Mtec 2004 (Birmingham NEC, 11-12 February 2004)
Beyond its use in proteomics research, the Axima-Tof2 is equally adept at analysing and processing polymers, oligonucleotides, SNPs, metabolites, lipids, carbohydrates or small molecules with extremely high sensitivity.
"Using high-energy CID to augment fragmentation of analytes, Shimadzu Biotech's Axima-Tof2 mass spectrometer takes full advantage of the curved field reflectron technology, to deliver MS/MS data without the need for post-acceleration", says Emmanuel Raptakis, product manager for Shimadzu Biotech.
Ion scattering is minimised by utilising a totally grid-less ion path and helium as the collision gas of choice.
The instrument is designed to have the highest ion transmission possible, thus optimizing real-world sensitivity.
"The Axima-Tof2 high energy CID has proven to be invaluable for a multitude of applications ranging from performing high confidence protein identification to aiding de novo sequencing", says Rachel Martin, applications manager for Shimadzu Biotech.
"Analysis of a wide variety of compound classes, like lipids and carbohydrates, can yield invaluable structural information previously out of reach for lower energy MS/MS approaches".
The novel ion gating technology employed in the Axima-Tof2 affords industry-leading precursor ion isolation resolution, which allows the successful MS/MS analysis of the most challenging complex mixtures.
The curved field reflectron technology, under license from Johns Hopkins University, MD, US, has been updated to enhance the sensitivity and quality of high energy CID MS/MS spectra.
The Axima-Tof2 is designed to seamlessly integrate with the wide Shimadzu Biotech product portfolio, to offer complete solutions.
Intuitive software allows the use of this device in an open access environment with minimal training, or within the most up-to-the-minute workflows, including automated PMF or MS-MS protein identification, LC-Maldi and others.
• Shimadzu Biotech: contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page

